Directional atherectomy use has risen among CAVEAT investigators, study finds.
This article was originally published in The Gray Sheet
Executive Summary
DIRECTIONAL CORONARY ATHERECTOMY USE HAS INCREASED among investigators in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) despite the study's adverse findings about the technique, Nowa Omoigui, et al. of the Cleveland Clinic Foundation, Cleveland, Ohio, and Duke University, Durham, North Carolina, reported in a poster presentation at the American College of Cardiology annual conference in New Orleans March 22.